| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.0098 | 0.9 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |